Inspire Medical Systems Inc. (INSP)
INSP trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1609550/000160955026000016/0001609550-26-000016-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | INSP on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001609550 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $912.0M |
| Net income | $145.4M |
| Operating income | $51.0M |
| Net margin | 15.9% |
| Operating margin | 5.6% |
| Revenue growth | +13.6% |
| Cash | $104.8M |
| Total assets | $907.3M |
| P/E (computed) | 11.8× |
| P/S (computed) | 1.9× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-02 |
| Cash and burn | $190.8M cash; operating cash flow $33.7M a quarter. | Report 2026-09-30 |
| Shares outstanding | 28,966,119 (2026-10-28); 29,056,434 a year earlier; 29,524,189 three years earlier. | Cover page 2026-10-28 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Ernst & Young LLP, Minneapolis, Minnesota, United States | PCAOB Form AP 2026-03-03 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $666K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $206.7M | -$24.4M | $46.4M | $190.8M | No debt tags | $880.9M | 10-Q 2026-11-02 |
| Q2 2026 2026-06-30 | $200.6M | $314K | $23.2M | $127.8M | No debt tags | $898.7M | 10-Q 2026-08-03 |
| Q1 2026 2026-03-31 | $204.6M | -$11.3M | $12.8M | $98.9M | No debt tags | $915.2M | 10-Q 2026-05-04 |
| Q4 2025 2025-12-31 | $269.1M | $136.1M | $52.5M | $104.8M | No debt tags | $912.0M | 10-K 2026-02-13 |
| Q3 2025 2025-09-30 | $224.5M | $9.9M | $68.5M | $112.8M | No debt tags | $882.6M | 10-Q 2026-11-02 |
| Q2 2025 2025-06-30 | $217.1M | -$3.6M | $2.7M | $106.9M | No debt tags | $861.3M | 10-Q 2026-08-03 |
| Q1 2025 2025-03-31 | $201.3M | $3.0M | -$6.7M | $53.9M | No debt tags | $840.1M | 10-Q 2026-05-04 |
| Q4 2024 2024-12-31 | $239.7M | $35.2M | $69.2M | $150.2M | No debt tags | $802.8M | 10-K 2026-02-13 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2022-08-15 |
| Latest annual report | 10-K | 2026-02-13 |
| Latest quarterly / interim | 10-Q | 2026-11-02 |
| Latest current report | 8-K | 2026-11-02 |
| Latest proxy | DEFA14A | 2026-03-20 |
Source: SEC EDGAR submissions feed, 900 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.5% |
| 1 month | -11.3% |
| 3 months | +5.0% |
| Year to date | -33.8% |
| 1 year | -29.6% |
| From 52-week high | -57.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| KMTS | Kestra Medical Technologies Ltd. | $27.97 | -2.34% | $1.7B |
| LMAT | LeMaitre Vascular Inc. | $77.01 | -1.63% | $1.8B |
| XRAY | DENTSPLY SIRONA Inc. | $8.95 | -2.35% | $1.8B |
| PRCT | PROCEPT BioRobotics Corporation | $23.54 | -1.09% | $1.4B |
| NVCR | NovoCure Limited | $11.30 | -4.48% | $1.3B |
| TNDM | Tandem Diabetes Care Inc. | $18.48 | -7.92% | $1.3B |
| UFPT | UFP Technologies Inc. | $298.54 | -2.14% | $2.3B |
| DRTS | Alpha Tau Medical Ltd. | $11.97 | -10.54% | $1.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier